(Q34093537)

31 July 2017

Accurate prediction of repeat prostate biopsy outcomes by a mitochondrial DNA deletion assay (English)

1 reference

31 July 2017

0 references

K Robinson

1

1 reference

31 July 2017

J Creed

2

1 reference

31 July 2017

B Reguly

3

1 reference

31 July 2017

C Powell

4

1 reference

31 July 2017

R Wittock

5

1 reference

31 July 2017

D Klein

6

1 reference

31 July 2017

A Maggrah

7

1 reference

31 July 2017

L Klotz

8

1 reference

31 July 2017

R L Parr

9

1 reference

31 July 2017

G D Dakubo

10

1 reference

31 July 2017

19 January 2010

1 reference

Prostate Cancer and Prostatic Diseases

31 July 2017

1 reference

31 July 2017

13

1 reference

31 July 2017

2

1 reference

31 July 2017

126-131

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2009.64

31 July 2017

0 references

cites work

Delineation of prognostic biomarkers in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Is interval from an initial biopsy a significant predictor of prostate cancer at repeat biopsies?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Predictors of prostate cancer after initial negative systematic 12 core biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Mitochondrial Genome Deletion Aids in the Identification of False- and True-Negative Prostate Needle Core Biopsy Specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Early identification of individuals with prostate cancer in negative biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Quantitative, spatial resolution of the epigenetic field effect in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

Clinical implications and utility of field cancerization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2009.64

31 March 2020

Identifiers

DOI

10.1038/PCAN.2009.64

1 reference

31 July 2017

1 reference